Biolase, Inc. · OTC:BIOLQ
Biolase — 6th Annual LD Micro Invitational (June 2016)
18 slides from Biolase's conference presentation, Jun 8, 2016
Slide 1: Transformational Technology from the World Leader in Dental Lasers
Transformational Technology from the World Leader in Dental Lasers Enabling Better Patient Reported Outcomes NASDAQ:BIOL Exhibit 99.1
Slide 2: Safe Harbor Statement
Statements made during BIOLASE’s presentation and in its representative’s answers to questions at the 6th annual LD Micro Invitational investor conference (the “Conference”) that refer to BIOLASE’s estimated or anticipated future results or other non-historical facts are forward-looking statements,
Slide 3: BIOLASE has been clear industry leader with more than 31,000 lasers sold
BIOLASE has been clear industry leader with more than 31,000 lasers sold and is best positioned as industry leader going forward Experienced leadership, strategy and plan now in place to achieve sustained growth, positive cash flow, and profitability Turnaround – significant opportunity exists for v
Slide 4: Biolase has a clear purpose, a focused mission, and values
Biolase has a clear purpose, a focused mission, and values that guide the shaping of a high performance culture Purpose: What we do for others - To restore & repair dental anatomy, alleviate pain, and reduce fear and anxiety related to dentistry to improve patient quality of life. Mission: What busi
Slide 5: Patient Promise: Better Outcomes & Less… Minimally Invasive Dental Microsurgery
Patient Promise: Better Outcomes & Less… Minimally Invasive Dental Microsurgery
Slide 6: Dentist Promise: Better Outcomes & More… Minimally Invasive Dental Microsurgery
Dentist Promise: Better Outcomes & More… Minimally Invasive Dental Microsurgery
Slide 7: Moving to a Whole Product approach to cross The Chasm
Previous product/technology sale orientation to early adopters moving to a “Whole Product” approach including required support to successfully address pragmatists Development of a differentiated “value tiered” product portfolio to access more markets around the world and significantly increase penet
Slide 8: The US Dental market has significant remaining opportunity for All-Tissue lasers
The US Dental market has significant remaining opportunity for All-Tissue lasers to penetrate clinics Improved Patient Reported Outcomes High prevalence, under-treated conditions High Volume Procedures THE OPPORTUNITY ADDRESSABLE MARKET TARGET MARKET SERVED UNSERVED 97,009 72,758 6,700 66,058 75% of
Slide 9: Global penetration at ~5% reinforces The Chasm not yet crossed
Global penetration at ~5% reinforces “The Chasm” not yet crossed to the early majority – significant opportunity exists High Volume Procedures Improved Clinical Outcomes Evidence-based THE OPPORTUNITY ADDRESSABLE MARKET TARGET MARKET SERVED UNSERVED 606,116 403,678 18,200 385,477 Sources: iData Rese
Slide 10: BIOLASE positioned well with dominant share in All-Tissue laser markets
BIOLASE positioned well with dominant share in All-Tissue laser markets and market leadership in Soft-Tissue lasers Soft Tissue Lasers Global Share All Tissue Lasers Global Share The majority of lasers sold are Soft Tissue devices. However, Biolase commands a dominant or significant share in both ma
Slide 11: Historical market revenue trends achieved mid to high single digit CAGR
Historical market revenue trends achieved mid to high single digit CAGR – BIOLASE can achieve mid to high teens CAGR (000s) Sources: iData Research 2014 reports; MarketMarkets Research 2015; industry and anecdotal reports. All Tissue Laser Market - Global Soft Tissue Laser Market - Global Total Dent
Slide 12: Proprietary Dental Lasers: Hard- & soft-tissue
Proprietary Dental Lasers: Hard- & soft-tissue WaterLase® iPlus - World’s top-selling all-tissue dental laser Energy generated by our proprietary laser wavelength excites water molecules in tissues and the main mineral in bone and teeth The water molecules within the tissue and the water spray absor
Slide 13: Compelling WaterLase value proposition with many benefits
Compelling WaterLase value proposition with many benefits – in process of being made simple and consistent for target segments Better Dentistry Better Patient Reported Outcomes Better ROI and business returns 80 FDA cleared indications, enabling significantly more procedures With 4 or less procedure
Slide 14: Two-thirds of 2015 revenue came from laser system sales
Two-thirds of 2015 revenue came from laser system sales and 55% the sales were made in the U.S. United States 55% International 45%
Slide 15: Harold C. Flynn, Jr. appointed President and CEO
Harold C. Flynn, Jr. appointed President and CEO in July 2015 Experienced medical device leader with world class companies in their respective sectors, IDEXX Laboratories, Abbott Laboratories, Zimmer Dental Leadership, technical, commercial and operating success in the dental, hematology and diagnos
Slide 16: Income Statement Comparative Financial Data Balance Sheet
Income Statement Comparative Financial Data Balance Sheet
Slide 17: Summary
World leader in dental laser systems having sold more than 31,000 dental laser systems Veteran top management team with successful dental industry and medical device experience leading the turnaround and transformation of BIOLASE Leader in large U.S. and global markets that have low penetration and
Slide 18: Questions and Answers
Questions and Answers BIOLASE
Biolase — 6th Annual LD Micro Invitational (June 2016) on 6ix